M
Matinas BioPharma Holdings Inc
AMEX:MTNB
Matinas BioPharma Holdings Inc
AMEX:MTNB
Price:
0.61
USD
-4.69%
Market Closed
Market Cap:
$3.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Matinas BioPharma Holdings Inc
AMEX:MTNB
|
US |
|
Axon Enterprise Inc
NASDAQ:AXON
|
US |
|
Universal Technologies Holdings Ltd
HKEX:1026
|
HK |
|
O
|
Onxeo SA
PAR:ALONX
|
FR |
|
M
|
Minesto AB
STO:MINEST
|
SE |
|
OrganiGram Holdings Inc
TSX:OGI
|
CA |
|
P
|
Philex Mining Corp
XPHS:PX
|
PH |
|
Elon AB (publ)
STO:ELON
|
SE |
|
Lazard Ltd
NYSE:LAZ
|
BM |
|
F
|
Fulcrum Metals PLC
LSE:FMET
|
UK |
Relative Value
There is not enough data to reliably calculate the relative value of MTNB.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MTNB
Relative Value
Base Case
Not Available
Multiples Across Competitors
MTNB Competitors Multiples
Matinas BioPharma Holdings Inc Competitors
Matinas BioPharma Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
M
|
Matinas BioPharma Holdings Inc
AMEX:MTNB
|
3.9m USD | 0 | -0.2 | 0.2 | 0.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.8B USD | 5.9 | 86.7 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.8B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD | 5.8 | 20.2 | 12.6 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.9B USD | 9.5 | 28.8 | 21.7 | 22.6 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD | 5.5 | 17.4 | 12.8 | 14.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD | 3.1 | 34.4 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
35.7B EUR | 10.1 | 32.6 | 35.1 | 35.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
